News about Market

Marksans Pharma Acquires Netherlands-Based QliniQ B.V. to Strengthen Europe Business

Marksans Pharma is set to acquire Netherlands-based QliniQ BV, a strategic move that expands its footprint in regulated European markets and strengthens its forward-integration strategy through direct market-access capabilities across the European Union (EU).

Market | 01/06/2026 | By News Bureau

Study Finds Comparable CAR T-Cell Therapy Outcomes Across Accredited and Non-Accredited Cancer Centres

A large-scale study involving more than 6,800 lymphoma patients found that CAR T-cell therapy delivered at non-FACT accredited centres achieved outcomes comparable to accredited facilities, supporting efforts to expand access to advanced cancer treatments closer to patients’ homes.

Market | 30/05/2026 | By News Bureau

SK bioscience Partners with Colombia's VECOL for Vaccine Technology Transfer and Local Manufacturing Initiative

SK Bioscience’s partnership with VECOL positions SK bioscience as a strategic technology transfer partner in Colombia’s national vaccine self-sufficiency initiative, supporting local manufacturing, public health preparedness and regional supply resilience.

Market | 28/05/2026 | By News Bureau

Asahi Kasei Life Science Acquires License for Novel ADC Technology from The Noguchi Institute

Asahi Kasei Life Science Secures Rights to Novel Antibody Drug Conjugate (ADC) Technology from The Noguchi Institute to Advance Safer and More Efficient Cancer Therapies

Market | 28/05/2026 | By News Bureau

NunaBio Raises Euro 6.5 Million to Scale Next-Generation DNA Manufacturing Platform

NunaBio’s latest funding to accelerate DNA micro-foundry development, expand manufacturing capabilities and strengthen infrastructure for synthetic biology, therapeutics, and research applications.

Market | 21/05/2026 | By News Bureau

Hansa Biopharma Signs IDEFIRIX Licensing Deal with SERB Pharmaceuticals for Europe and MENA

Hansa Biopharma signs a €115 million licensing agreement with SERB Pharmaceuticals for commercialisation of IDEFIRIX across Europe and MENA, strengthening its financial position ahead of a potential US launch.

Market | 21/05/2026 | By News Bureau

Samsung Bioepis Launches First Biosimilar Product in Japan with Ustekinumab Therapy

Samsung Bioepis launches its ustekinumab biosimilar in Japan through a partnership with Nipro Corporation, expanding access to affordable treatments for chronic autoimmune diseases.

Market | 21/05/2026 | By News Bureau

Dr. Reddy's Launches Oral Semaglutide Biosimilar Obeda Tablets in India

Dr. Reddy's launches Obeda oral semaglutide tablets in India, strengthening its GLP-1 portfolio after recent generic semaglutide injection launches in India and Canada for diabetes and obesity care.

Market | 20/05/2026 | By News Bureau

InMed Pharmaceuticals and Mentari Therapeutics Mergers to Advance Next-Generation Migraine Therapies

InMed Pharmaceuticals and Mentari Therapeutics have entered into a definitive merger agreement, combining Mentari’s migraine-focused drug pipeline with InMed’s public market infrastructure to support the development of innovative therapies targeting chronic and episodic migraine.

Market | 20/05/2026 | By News Bureau

Zydus Lifesciences Completes Investment in Torrent Urja 25 with Rs 90.18 Million Share Subscription

Zydus Lifesciences and its subsidiaries have completed the final tranche of investment in Torrent Urja 25, subscribing to equity shares worth Rs 90.18 million and concluding the transaction initiated under the Share Subscription and Shareholders’ Agreements (SSSAs).

Market | 20/05/2026 | By News Bureau |  116